Mitteldorf, C.; Grabbe, S.; Stadler, R.
WHO classification and clinical spectrum of cutaneous lymphomasHAUTARZT. Bd. 68. H. 9. 2017 S. 682-695
Saloga, Joachim; Grabbe, Stephan
28th Mainzer Allergy WorkshopALLERGO JOURNAL. Bd. 25. H. 1. 2016 S. 36-36
Maurer, M.; Chapman-Rothe, N.; Staubach, P. et al.
A big Online- Patient Survey on Chronic Urticaria revealed a high Level of Suffering and inadequate Symptom Control for Sufferers under Everyday ConditionsJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 11-11
Maurer, M.; Staubach, P.; Raap, U. et al.
A broad patient directed online survey reveals high burden of chronic urticaria and under treatment in a real life settingALLERGY. Bd. 71. 2016 S. 183-183
Bork, Konrad
A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE)CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. Bd. 51. H. 2. 2016 S. 183-192
Cosgarea, I.; Franklin, C.; Schwamborn, M. et al.
A distinct role for eosinophil and neutrophil granulocytes in patients with advanced melanoma receiving selective BRAF inhibitorsEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E34-E34
Jabulowsky, Robert A.; Loquai, Carmen; Diken, Mustafa et al.
A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanomaCANCER RESEARCH. Bd. 76. 2016
Hahn, Susanne A.; Neuhoff, Annemarie; Landsberg, Jenny et al.
A key role of GARP in the immune suppressive tumor microenvironmentONCOTARGET. Bd. 7. H. 28. 2016 S. 42996-43009
Jabulowsky, Robert A.; Loquai, Carmen; Diken, Mustafa et al.
A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanomaCANCER IMMUNOLOGY RESEARCH. Bd. 4. H. 1. 2016
Werfel, T.; Lynch, V; Asher, A. et al.
A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389), a potent, oral histamine H-4 receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adultsALLERGY. Bd. 71. 2016 S. 95-95